Biome Grow Inc. (CSE:BIO)(“Biome”) is pleased to announce the appointment of Rita Theil as an independent member of its Board of Directors effective immediately.  Ms. Theil has extensive governance experience at the board level of both public and private companies, with a particular focus on enterprises operating in highly regulated industries.  She is currently President and Chief Executive Officer of JacKryn Holdings Inc., which is a leading corporate finance advisory firm specializing in capital markets, strategy development and execution, M&A and merger integration. In 2003, Ms. Theil also established the Women’s Mentor Initiative.

Her current and former independent board assignments include Allstate Insurance Company of Canada, NewGen Asset Management, WATERTAP Ontario, Global Water Resources Inc., and Scottish Water plc.


Ms. Theil has a professional background as a corporate lawyer, as well as extensive and varied experience as an investment banker. At CITIBANK – Schroder Salomon Smith Barney, she served as Director, European Utilities, Water, and Infrastructure. During her tenure at CITIBANK, she also founded CITI WOMEN, an organization formed to be a leader in attracting, developing, advancing, and retaining female talent at all levels. Prior to CITIBANK, she was an Assistant Director at Dresdner Kleinwort Benson where she worked on the privatization of the UK electricity industry and built the power advisory investment banking business for the United States and Canada.

“Biome is excited to have Rita join our board of directors.  As with our current members of the Biome Board, she will bring considerable strategic value to the operations of the company beyond her duties as a board member. In particular, her extensive international mergers and acquisitions experience, risk matrix development, and advisory work with governments will play a key role as Biome looks to expand on its international cannabis footprint” said Khurram Malik, President and Chief Executive Officer of Biome.  “In addition, her leadership in diversity and mentoring initiatives aligns well with our ‘Conscious Cannabis’ mantra as we continue to promote a culture of corporate social responsibility.”

“I am honoured to join Biome’s Board of Directors and share my international capital markets experience and my corporate governance and regulatory perspectives in support of Biome’s continued growth across Canada and foreign markets,” said Rita Theil.  “Biome is a fast-growing player in the Canadian medical cannabis sector and I am looking forward to bringing my experiences and insights to the table to help broaden its scope.”

Ms. Theil holds a Master of Business Administration degree (International Strategy and Management) from the University of Ottawa, as well as an LLB and a Bachelor of Social Science from the same institution.  She is a chartered director and the recipient of numerous awards and honours.

For further information, please contact:

Scott Cuthbertson
VP Investor Relations
scuthbertson@biomegrow.com
647-462-8797
www.biomegrow.com

About Biome

Biome wholly owns five subsidiaries, including: The Back Home Medical Cannabis Corporation, a company incorporated under the laws of the Province of Newfoundland and Labrador and in the late stages of applying for a license under the Cannabis Act; Great Lakes Cannabis, a company incorporated under the laws of the Province of Ontario and in the late stages of applying for a license under the Cannabis Act; Highland Grow Inc., a licensed producer in Nova Scotia under the Cannabis Act; Red Sands Craft Cannabis Co., a company incorporated under the laws of the Province of Prince Edward Island; and Weed Virtual Retail Inc., a company incorporated under the laws of the Province of Ontario in the business of operating a new virtual reality technology platform focused exclusively on the medical and recreational cannabis markets. Biome is a Canadian-based company with national and international business interests.

Click here to connect with Biome Grow Inc. (CSE:BIO) for an Investor Presentation. 

Source: www.globenewswire.com

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less